Medisigma Pharma Private Limited
About Medisigma Pharma Private Limited
Data last updated:
Medisigma Pharma Private Limited is a private limited company based in Thane, Maharashtra, India. It operates in the specialised services segment of the trading and commerce sector. It was incorporated on 23 July 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U51909MH2021PTC364517.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Jogendra Bhaiyaram Mourya and Sudhakar Ramaprakash Tiwari.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Flat No 201 2nd Floor Building No 29 Maitri Park H No 2272/19 Kasheli, Thane, Maharashtra, India – 421302.
As per the financials filed for FY 2025, the company reported a revenue of ₹7.74 Lakh, a decline of 79% compared to the previous year. For the same year it recorded a net loss of ₹8.15 Lakh (net margin -105.3%) and EBITDA of -₹8.11 Lakh (EBITDA margin -104.9%).
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressFlat No 201 2nd Floor Building No 29 Maitri Park H No 2272/19 Kasheli, Thane, Maharashtra, India – 421302
- IndustryTrading, Specialty, Wholesale
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Medisigma Pharma Private Limited
The main business activity of Medisigma Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Medisigma Pharma Private Limited FY 2025 filings available
Medisigma Pharma Private Limited reported revenue of ₹7.74 Lakh (down 79% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Medisigma Pharma Private Limited
Revenue fell 79% in the latest year. EBITDA fell 901% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Medisigma Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• |
| EBITDA | -₹8.11 Lakh | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | -₹8.15 Lakh | •••• | •••• | •••• |
| Balance Sheet | ||||
| Share Capital | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• |
Financial Ratios of Medisigma Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | -104.9% | •••• | •••• | •••• |
| Net Profit Margin | -105.3% | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• |
| Liquidity and Debt | ||||
| Current Ratio | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• |
| Efficiency and Growth | ||||
| Asset Turnover | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Medisigma Pharma are in the company report.
Financial statements from FY 2022
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Medisigma Pharma Private Limited
Medisigma Pharma Private Limited is compared with the companies closest to it by revenue in the same principal business activity (Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Ido Chemical Industries Private Limited | ₹7.84 Lakh (FY 2024) | •••• | •••• | -54.0% | •••• | Satara, Maharashtra, India |
| P K Vaidyars Vaidya Ratna Prabha Vaidya Sala Private Limited | ₹7.83 Lakh (FY 2024) | •••• | •••• | -53.0% | •••• | Malappuram, Kerala, India |
| JV Crop Science Private Limited | ₹7.8 Lakh (FY 2020) | •••• | •••• | 449.0% | •••• | Bulandshahr, Uttar Pradesh, India |
| Pentcure Pharmaceuticals Private Limited | ₹7.77 Lakh (FY 2020) | •••• | •••• | 54.0% | •••• | Lucknow, Uttar Pradesh, India |
| Marbinio Bricenio Private Limited | ₹7.75 Lakh (FY 2024) | •••• | •••• | 26.0% | •••• | Bhopal, Madhya Pradesh, India |
| Medisigma Pharma Private Limited this company | ₹7.74 Lakh (FY 2025) | •••• | •••• | -79.0% | •••• | Thane, Maharashtra, India |
| Manogii Private Limited | ₹7.72 Lakh (FY 2024) | •••• | •••• | 65.0% | •••• | Delhi, India |
| Columna Industries Private Limited | ₹7.72 Lakh (FY 2021) | •••• | •••• | •••• | Ajmer, Rajasthan, India | |
| Avishkar Biofarm Private Limited | ₹7.7 Lakh (FY 2019) | •••• | •••• | -27.0% | •••• | Ahmednagar, Maharashtra, India |
| Akhilam Pharmaceuticals Pvt Ltd | ₹7.7 Lakh (FY 2024) | •••• | •••• | 4.0% | •••• | Kannur, Kerala, India |
| Loma Healthcare Private Limited | ₹7.7 Lakh (FY 2024) | •••• | •••• | •••• | Panchkula, Haryana, India |
Peers are the five companies nearest above and the five nearest below Medisigma Pharma by revenue in the same principal business activity (Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Board of Directors of Medisigma Pharma Private Limited
Medisigma Pharma has 2 current directors and 8 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Jogendra Bhaiyaram Mourya | Director | 25 Aug 2022 | 4 Years 1 Months | Current |
| Sudhakar Ramaprakash Tiwari | Director | 19 Jan 2026 | 0 Years 8 Months | Current |
Charges & Borrowings of Medisigma Pharma Private Limited
Medisigma Pharma Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Medisigma Pharma Private Limited
Employment history and EPFO contributions of people linked to Medisigma Pharma.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Medisigma Pharma Private Limited
Medisigma Pharma Private Limited has 10 board changes on record since 2022: 3 appointments and 7 cessations. The latest: Sudhakar Ramaprakash Tiwari was appointed as Director on 19 Jan 2026.
1 earlier event is listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Medisigma Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Medisigma Pharma Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Medisigma Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Medisigma Pharma Private Limited
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Medisigma Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Medisigma Pharma Private Limited
Medisigma Pharma is an active private limited company based in Thane, Maharashtra, India. The company works in specialty, within the trading industry. It was incorporated on 23 July 2021 (5+ years old) and is registered under CIN U51909MH2021PTC364517.
Medisigma Pharma reported revenue of ₹7.74 Lakh for FY 2025 (down 79% YoY).
Medisigma Pharma has 2 current directors:
- Jogendra Bhaiyaram Mourya - Director
- Sudhakar Ramaprakash Tiwari - Director
Medisigma Pharma reported a net loss of ₹8.15 Lakh (net margin -105.3%) and EBITDA of -₹8.11 Lakh (EBITDA margin -104.9%) for FY 2025, as per its filed financial statements.
The CIN (Corporate Identification Number) of Medisigma Pharma is U51909MH2021PTC364517. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Medisigma Pharma was incorporated on 23 July 2021, making it 5+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Medisigma Pharma by revenue are Ido Chemical Industries Private Limited, P K Vaidyars Vaidya Ratna Prabha Vaidya Sala Private Limited, JV Crop Science Private Limited, Pentcure Pharmaceuticals Private Limited, Marbinio Bricenio Private Limited and 5 more, all in the same principal business activity (Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Sudhakar Ramaprakash Tiwari was appointed as Director on 19 Jan 2026. Kaushal Yadav ceased to be Director on 26 Aug 2024. Pradeep Kumar ceased to be Director on 28 Jul 2024. Medisigma Pharma has 10 board changes on record in total.
The registered office of Medisigma Pharma is at Flat No 201 2nd Floor Building No 29 Maitri Park H No 227219 Kasheli, Thane, Maharashtra, India – 421302.
Medisigma Pharma has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh.
Medisigma Pharma operates in the trading industry, in the specialty segment.